Author:
Parmiani G.,Arienti F.,Belli F.,Santinami M.,Vaglini M.,Cascinelli N.
Reference33 articles.
1. Aebersold, P., Hyatt, C., Johnson, S., Hines, K., Korcak, L., Sanders, M., Lotze, M., Topalian, S., Yang, J., Rosenberg, S. A. (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J. Natl. Cancer Inst. 83: 932–937.
2. Anichini, A., Mazzocchi, A., Fossati, G., Parmiani, G. (1989) Cytotoxic T lymphocytes clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanism of interaction. J. Immunol. 142: 3693–3701.
3. Arienti, F., Belli F., Rivoltini, L., Gambacorti-Passerini, C., Furlan, L., Mascheroni, L., Prada, A., Rizzi, M., Marchesi, M., Vaglini, M., Parmiani, G., Cascinelli, N. (1993) Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor infiltrating lymphocytes (TIL) selected in vitro with low doses of IL-2. Cancer Immunol. Immunother. (in press).
4. Atzpodien, J., Korfer, A., Franks, C. R., Paliwoda, H., Kirchner, H. (1990) Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies. Lancet 335: 1509–1512.
5. Balch, C. M., Riley, L. B., Bae, Y. J., Salmeron, M. A., Platsoucas, C. D., von Eschenbach, A., Itoh, K. (1990) Patterns of human tumour-infiltrating lymphocytes in 120 human cancers. Arch. Surg. 12: 200–205.